A Double-blind, Single and Multiple Ascending Dose, Randomised, Placebo-controlled Study, in Healthy Adult and Elderly Subjects Exploring Safety, Tolerability, Pharmacokinetics of ONO-4474 and Pharmacology of ONO-4474 in NGF-hyperalgesia
Phase of Trial: Phase I
Latest Information Update: 07 Jul 2016
At a glance
- Drugs ONO 4474 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors Ono Pharmaceutical
- 29 Jun 2016 Status changed from recruiting to completed.
- 26 Jan 2016 Planned End Date changed from 1 Jun 2017 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
- 26 Jan 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jun 2016 as reported by ClinicalTrials.gov record.